Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization. Past successes, future challenges

M Grossman1

  • 1San Francisco General Hospital, California, USA.

Infectious Disease Clinics of North America
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.

Acta neuropathologica communications·2021
Same author

Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology.

Alzheimer's research & therapy·2021
Same author

Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.

Neuropathology and applied neurobiology·2020
Same author

The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.

The British journal of dermatology·2020
Same author

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Immunization programs have achieved global smallpox eradication and polio elimination. Continued challenges in developing nations highlight the need for new vaccine development and delivery strategies.

Area of Science:

  • Public Health
  • Immunology
  • Vaccinology

Background:

  • Immunization programs have led to significant global health successes, including smallpox eradication and poliomyelitis elimination.
  • Despite successes, substantial challenges persist, particularly in developing countries, necessitating ongoing efforts.

Observation:

  • Notable achievements include the global eradication of smallpox and the elimination of poliomyelitis in the Western Hemisphere.
  • A significant 90% reduction in Haemophilus influenzae meningitis cases in the Western Hemisphere demonstrates vaccine impact.

Findings:

  • While past immunization efforts have been highly successful, many serious health issues remain prevalent, especially in developing regions.
  • Current challenges underscore the critical need for continued innovation in vaccine development and distribution.

Related Experiment Videos

Implications:

  • Advances in biotechnology offer promising avenues for developing novel vaccines.
  • Renewed interest from industry, governments, and the World Health Organization signals a potential for major progress in global immunization over the next decades.